Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors

NCT05037825 is registered in ClinicalTrials.gov with VastBiome as lead sponsor.

NCT NCT05037825
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05037825 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors
Lead sponsor
VastBiome
Phase
Observational
Overall status
Recruiting
Start date
November 22, 2021
Completion date
September 14, 2028
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma, non-small-cell lung carcinoma, renal cell carcinoma, triple-negative breast cancer